# Pentagon mandates testosterone testing for 2M troops, no cost disclosed

- URL: https://twotakes.us/stories/pentagon-mandates-testosterone-testing-for-2m-troops-no-cost-disclosed
- Published: 2026-09-20T07:08:36.473803+00:00
- Topics: pentagon, military-health, hegseth, defense-policy, government-spending

## What the left says
- The policy initially included plans to ask female service members about fatigue and menstrual irregularities tied to hormonal issues, and the exclusion of women from the finalized guidance raises questions about equitable health coverage across the force.
- The abrupt rescinding and reposting of guidance, with a Pentagon adviser calling the first version an inadvertently posted 'draft,' suggests the policy was rolled out without full internal coordination or vetting.
- Framing testosterone therapy as a readiness and performance tool echoes broader concerns about the politicization of military health policy under this administration, particularly its ties to messaging around masculinity and 'Operator Syndrome.'
- Mandating invasive, repeated blood testing for millions of troops warrants scrutiny over privacy, medical autonomy, and whether such screening is driven by sound clinical evidence or ideological priorities.

## What the right says
- Identifying and treating low testosterone is a legitimate readiness investment, since hormonal deficiencies can affect strength, energy, and recovery critical to warfighter performance.
- Soldiers face documented elevated risk of hypogonadism, so proactive screening reflects sound, targeted medical policy rather than an unusual or frivolous initiative.
- The Pentagon's refusal to disclose cost estimates despite repeated inquiries raises legitimate taxpayer accountability concerns, especially for a program affecting roughly 2 million service members.
- The Defense Department's own acknowledgment that it doesn't know how many troops will need testing or treatment suggests the program was announced before basic budgeting and logistics were worked out.

## Common ground
- The screening applies to all active-duty and reserve male service members aged 30 and older, covering roughly 2 million troops.
- The guidance was temporarily rescinded and then reissued within a two-week span, with a Pentagon adviser describing the earlier version as an inadvertently posted draft.
- Neither the original July memo nor the new clinical guidance includes a cost estimate or specifies funding sources.
- Rules for screening female service members have not yet been finalized and will be addressed separately at a later date.

## Sources
- [ABC News](https://abcnews.com/Health/pentagon-posts-new-guidance-mandatory-testosterone-screening/story?id=136562269) (Lean Left)
- [Just The News](https://justthenews.com/nation/states/center-square/testosterone-screening-2m-troops-comes-no-cost-estimate?utm_source=justthenews.com&utm_medium=feed&utm_campaign=external-news-aggregators) (Right)
- [The Economist](https://www.economist.com/united-states/2026/07/17/pete-hegseths-testosterone-screening-plan-is-unusual-not-crazy) (Lean Right)
- [The Hill](https://thehill.com/policy/defense/6097148-pentagon-new-male-testosterone-screening/) (Center)
- [Washington Post](https://www.washingtonpost.com/national-security/2026/09/18/pentagon-issues-testosterone-screening-guidance-male-troops/) (Lean Left)

---
Content by TwoTakes (https://twotakes.us). You may quote, summarize and cite it, including in AI answers, as long as you credit TwoTakes and link the story URL. Original reporting belongs to the linked outlets. Summaries are AI-assisted and reviewed for balance; check the original sources for authoritative reporting.